My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1423

    1.

    Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials.

    Kyndi M, Sørensen FB, Knudsen H, Alsner J, Overgaard M, Nielsen HM, Overgaard J; Danish Breast Cancer Cooperative Group.

    Breast Cancer Res. 2008;10(2):R24. Epub 2008 Mar 20.

    PMID:
    18355402
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

    Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J; Danish Breast Cancer Cooperative Group.

    J Clin Oncol. 2008 Mar 20;26(9):1419-26. Epub 2008 Feb 19.

    PMID:
    18285604
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c.

    Kyndi M, Sørensen FB, Knudsen H, Alsner J, Overgaard M, Nielsen HM, Overgaard J.

    Acta Oncol. 2008;47(4):608-17.

    PMID:
    18465329
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

    Brennan DJ, Jirstrom K, Kronblad A, Millikan RC, Landberg G, Duffy MJ, Rydén L, Gallagher WM, O'Brien SL.

    Clin Cancer Res. 2006 Nov 1;12(21):6421-31.

    PMID:
    17085655
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    5.

    Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.

    Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH.

    Br J Cancer. 2007 Jan 15;96(1):104-9.

    PMID:
    17213826
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    6.

    Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

    Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT.

    Lancet. 1999 May 15;353(9165):1641-8.

    PMID:
    10335782
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

    Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M.

    J Natl Cancer Inst. 2005 Jan 19;97(2):116-26.

    PMID:
    15657341
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    8.

    Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.

    Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.

    Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47.

    PMID:
    15817335
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.

    Kyndi M, Overgaard M, Nielsen HM, Sørensen FB, Knudsen H, Overgaard J.

    Radiother Oncol. 2009 Jan;90(1):74-9. Epub 2008 May 28.

    PMID:
    18471914
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

    Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K.

    N Engl J Med. 1997 Oct 2;337(14):949-55.

    PMID:
    9395428
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    11.

    Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.

    Danish Breast Cancer Cooperative Group, Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J.

    J Clin Oncol. 2006 May 20;24(15):2268-75. Epub 2006 Apr 17.

    PMID:
    16618947
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials.

    Rutqvist LE, Cedermark B, Glas U, Johansson H, Rotstein S, Skoog L, Somell A, Theve T, Askergren J, Friberg S, et al.

    Int J Radiat Oncol Biol Phys. 1989 Mar;16(3):629-39.

    PMID:
    2493433
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.

    Tormey DC, Gray R, Falkson HC.

    J Natl Cancer Inst. 1996 Dec 18;88(24):1828-33.

    PMID:
    8961972
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    14.

    Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.

    Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL.

    J Clin Oncol. 2001 Aug 15;19(16):3660-8.

    PMID:
    11504747
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial.

    Gluz O, Nitz UA, Harbeck N, Ting E, Kates R, Herr A, Lindemann W, Jackisch C, Berdel WE, Kirchner H, Metzner B, Werner F, Schütt G, Frick M, Poremba C, Diallo-Danebrock R, Mohrmann S; West German Study Group.

    Ann Oncol. 2008 May;19(5):861-70. Epub 2008 Jan 3.

    PMID:
    18174609
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    16.

    Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.

    Overgaard M, Nielsen HM, Overgaard J.

    Radiother Oncol. 2007 Mar;82(3):247-53. Epub 2007 Feb 15.

    PMID:
    17306393
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.

    Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J.

    Radiother Oncol. 2006 May;79(2):147-55. Epub 2006 Apr 27.

    PMID:
    16647152
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy.

    Dunst J, Steil B, Furch S, Fach A, Lautenschläger C, Diestelhorst A, Lampe D, Kölbl H, Richter C.

    Strahlenther Onkol. 2001 Oct;177(10):504-10.

    PMID:
    11680014
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.

    Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N.

    J Clin Oncol. 2004 Nov 1;22(21):4247-54. Epub 2004 Sep 27.

    PMID:
    15452182
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer.

    Lee JC, Truong PT, Kader HA, Speers CH, Olivotto IA.

    Clin Oncol (R Coll Radiol). 2005 Dec;17(8):623-9.

    PMID:
    16372488
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk